MDS (Myelodysplastic Syndrome)

Explore clinical trials studying MDS (Myelodysplastic Syndrome). Study availability and eligibility vary by location and protocol.

27 public trials 16 recruiting studies

Refine in advanced search Browse all conditions

MDS (Myelodysplastic Syndrome) trial results

Not yet recruiting

A Long-term Follow-up Study of Patients With ARD103 CAR-T Cell Therapies

NCT06906380

Conditions: Acute Myeloid Leukemia, in Relapse, Acute Myeloid Leukemia, in Relapsed or Refractory, Anemia, +12 more
Locations: Novant Health Cancer Institute Charlotte, North Carolina, United States

Novant Health Cancer Institute Winston-Salem, North Carolina, United States

MD Anderson Cancer Center Houston, Texas, United States

View Trial Details

Not yet recruiting

Venetoclax- Augmented Treosulfan-Based Reduced Intensity Conditioning Before Allogeneic Stem Cell Transplantation

NCT07214064

Conditions: AML (Acute Myeloid Leukemia), Anemia, Anemia, Refractory, +12 more
Locations: University Hospital , Department of Internal Medicine II Tübingen, Baden-Wurttemberg, Germany

View Trial Details

Active, not recruiting

A First-in-Human Study of HLA-Partially to Fully Matched Allogenic Cryopreserved Deceased Donor Bone Marrow Transplantation for Patients With Hematologic Malignancies

NCT05589896

Conditions: Acute Biphenotypic Leukemia, Acute Leukemia, Acute Lymphoblastic Leukemia, +39 more
Locations: City of Hope Duarte, California, United States

Moffitt Cancer Center Tampa, Florida, United States

Emory University - Winship Cancer Institute Atlanta, Georgia, United States

Henry Ford Cancer Institute Detroit, Michigan, United States

View Trial Details

Active, not recruiting

A Single-Arm, Open Phase I Clinical Study of Selinexor in Combination With Azacitidine for the Treatment of High-Risk AML/MDS Patients After Allo-HSCT

NCT07779031

Conditions: Acute Myeloid Leukaemia (AML), Anemia, Anemia, Refractory, +11 more
Locations: Chinese PLA General Hospital Beijing, China

View Trial Details

Completed

Personalized Medicine Program on Myelodysplastic Syndromes: Characterization of the Patient's Genome for Clinical Decision Making and Systematic Collection of Real World Data to Improve Quality of Health Care

NCT04212390

Conditions: Anemia, Anemia, Refractory, Anemia, Refractory, with Excess of Blasts, +5 more
Locations: IRCCS Humanitas Research Hospital Rozzano, Milano, Italy

Elena Crisà Candiolo, Torino, Italy

View Trial Details

Completed

Preventing Stem Cell Transplant Complications With a Blood Separator Machine

NCT01866839

Conditions: ALL (Acute B-Lymphoblastic Leukemia), AML (Acute Myelogenous Leukemia, Anemia, +29 more
Locations: National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States

View Trial Details

Completed

Stem Cell Transplantation for Patients With Cancers of the Blood

NCT00467961

Conditions: AML (Acute Myelogenous Leukemia), Acute Lymphocytic Leukemia, Anemia, +28 more
Locations: National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States

View Trial Details

MDS (Myelodysplastic Syndrome)

MDS (Myelodysplastic Syndrome) trial results

A Long-term Follow-up Study of Patients With ARD103 CAR-T Cell Therapies

Venetoclax- Augmented Treosulfan-Based Reduced Intensity Conditioning Before Allogeneic Stem Cell Transplantation

A First-in-Human Study of HLA-Partially to Fully Matched Allogenic Cryopreserved Deceased Donor Bone Marrow Transplantation for Patients With Hematologic Malignancies

A Single-Arm, Open Phase I Clinical Study of Selinexor in Combination With Azacitidine for the Treatment of High-Risk AML/MDS Patients After Allo-HSCT

Personalized Medicine Program on Myelodysplastic Syndromes: Characterization of the Patient's Genome for Clinical Decision Making and Systematic Collection of Real World Data to Improve Quality of Health Care

Preventing Stem Cell Transplant Complications With a Blood Separator Machine

Stem Cell Transplantation for Patients With Cancers of the Blood

Related conditions